- Investing Ideas
- Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
72
Companies with a Value score of at least 3, ordered by Value score
72 companies
Regeneron Pharmaceuticals
Market Cap: Mex$65.0b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN *
Mex$10,825.00
7D
-11.5%
1Y
n/a
Halozyme Therapeutics
Market Cap: Mex$8.1b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.
HALO *
Mex$1,192.50
7D
0%
1Y
17.2%
Neurocrine Biosciences
Market Cap: Mex$15.8b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX *
Mex$2,716.41
7D
-1.3%
1Y
n/a
Ardelyx
Market Cap: Mex$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX *
Mex$128.00
7D
0%
1Y
n/a
Ascendis Pharma
Market Cap: Mex$15.3b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND1 N
Mex$3,919.60
7D
0%
1Y
n/a
IQVIA Holdings
Market Cap: Mex$28.0b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV *
Mex$2,889.12
7D
-5.2%
1Y
3.5%
Vaxart
Market Cap: Mex$117.4m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.
VXRT *
Mex$12.00
7D
0%
1Y
n/a
CSPC Pharmaceutical Group
Market Cap: Mex$69.4b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093 N
Mex$15.69
7D
0%
1Y
-27.0%
GSK
Market Cap: Mex$57.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK1 N
Mex$356.95
7D
0%
1Y
n/a
Zai Lab
Market Cap: Mex$3.5b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB N
Mex$810.00
7D
0%
1Y
n/a
Grifols
Market Cap: Mex$6.9b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF N
Mex$257.03
7D
0%
1Y
n/a
Caris Life Sciences
Market Cap: Mex$5.1b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI *
Mex$493.00
7D
0%
1Y
n/a
Organon
Market Cap: Mex$3.5b
Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
OGN *
Mex$245.00
7D
0%
1Y
63.3%
Novartis
Market Cap: Mex$227.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN N
Mex$2,487.40
7D
0%
1Y
n/a
Novo Nordisk
Market Cap: Mex$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVOB N
Mex$782.00
7D
-6.6%
1Y
-39.9%
Zoetis
Market Cap: Mex$34.1b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS *
Mex$1,368.00
7D
6.9%
1Y
-56.8%
Novavax
Market Cap: Mex$1.5b
A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
NVAX *
Mex$157.83
7D
-1.4%
1Y
14.2%
Genomma Lab Internacional. de
Market Cap: Mex$15.2b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$15.58
7D
-1.0%
1Y
-26.5%
BeiGene
Market Cap: Mex$14.0b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
BGNE N
Mex$2,858.16
7D
0%
1Y
n/a
Perrigo
Market Cap: Mex$3.7b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO N
Mex$557.52
7D
0%
1Y
n/a
Jazz Pharmaceuticals
Market Cap: Mex$10.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ N
Mex$2,500.00
7D
0%
1Y
n/a
Viatris
Market Cap: Mex$19.4b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS *
Mex$300.00
7D
0%
1Y
n/a
CRISPR Therapeutics
Market Cap: Mex$4.9b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP N
Mex$835.42
7D
-7.2%
1Y
14.9%
Novo Nordisk
Market Cap: Mex$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO N
Mex$778.45
7D
0.4%
1Y
-39.8%
Gilead Sciences
Market Cap: Mex$166.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD *
Mex$2,325.00
7D
2.3%
1Y
17.3%
Illumina
Market Cap: Mex$21.8b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN *
Mex$2,510.00
7D
0%
1Y
55.4%
Telix Pharmaceuticals
Market Cap: Mex$4.7b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX1 N
Mex$302.55
7D
0%
1Y
n/a
ACADIA Pharmaceuticals
Market Cap: Mex$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD *
Mex$382.00
7D
0%
1Y
n/a
Bayer
Market Cap: Mex$37.8b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN N
Mex$781.81
7D
0%
1Y
53.3%
Biogen
Market Cap: Mex$28.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB *
Mex$3,350.00
7D
1.6%
1Y
37.0%
Vertex Pharmaceuticals
Market Cap: Mex$110.3b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX *
Mex$7,535.28
7D
-3.0%
1Y
-9.8%
Thermo Fisher Scientific
Market Cap: Mex$166.6b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO *
Mex$7,704.00
7D
1.4%
1Y
1.5%
Astellas Pharma
Market Cap: Mex$4.1t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503 N
Mex$253.57
7D
0%
1Y
n/a
Amgen
Market Cap: Mex$183.1b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN *
Mex$5,858.00
7D
3.3%
1Y
10.5%
Novartis
Market Cap: Mex$227.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS N
Mex$2,638.00
7D
2.8%
1Y
26.1%
Haleon
Market Cap: Mex$30.5b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN1 N
Mex$161.00
7D
0.7%
1Y
n/a